Potential Therapeutic Targets for Steroid-Resistant Asthma
- 1 August 2010
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Targets
- Vol. 11 (8), 957-970
- https://doi.org/10.2174/138945010791591412
Abstract
Glucocorticoids are the mainstay of asthma management and effectively treat acute exacerbations of asthma. However, a small subset of asthmatics, usually with severe asthma, respond poorly even to systemic administration of high-dose glucocorticoids and this condition is termed “steroid-resistant asthma”. This cohort, although small, accounts for ~50% of total health care cost for asthma. New investigations into the mechanisms of glucocorticoid action have broadened and deepened our understanding of glucocorticoid resistance. Here we review the importance and characteristics of steroid resistant asthma, the mechanisms that mediate the function of glucocorticoids and that lead to the development of this disease and potential therapies to reverse resistance to treatment. Cellular and molecular factors, receptors and complex signalling pathways have all been implicated. Indeed, based on molecular biological studies, excessive activation of intracellular transcription factors, impaired histone deacetylase, and epigenetic (such as miR-18 and miR-124a) as well as other factors (e.g. vitamin D, P-glycoprotein 170, and macrophage migration inhibitory factor and T helper 17 cells and factors related to innate immunity (such as IFN-γ and LPS)) may result in glucocorticoid resistance. A thorough understanding of the pathogenesis of steroid resistant asthma will help to develop more efficacious agents for the treatment of the disease.Keywords
This publication has 77 references indexed in Scilit:
- Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretionBrain, Behavior, and Immunity, 2009
- The PKC and ERK/MAPK Pathways Regulate Glucocorticoid Action on TRH TranscriptionNeurochemical Research, 2008
- Targeting phosphoinositide 3-kinase—Moving towards therapyBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008
- Corticosteroids: The drugs to beatEuropean Journal of Pharmacology, 2006
- Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid‐induced expression of mitogen‐activated protein kinase phosphatase‐1European Journal of Immunology, 2005
- Molecular Mechanisms and Cellular Effects of GlucocorticosteroidsImmunology and Allergy Clinics of North America, 2005
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Intron-derived microRNAs—fine tuning of gene functionsGene, 2004
- Physical defeat reduces the sensitivity of murine splenocytes to the suppressive effects of corticosteroneBrain, Behavior, and Immunity, 2004
- Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitrationBiochemical and Biophysical Research Communications, 2004